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Abstract
Background: Recent evidence from rodent ovaries has demonstrated expression of fractalkine and the existence of
fractalkine receptor, and showed that there is a significant increase in steroidogenesis in response to fractalkine, yet
the role of fractalkine and CX3CR1 in the human ovary is still unknown. This study aimed to determine the
expression levels of fractalkine and CX3CR1 in the human ovary and to investigate their roles in sexual hormone
biosynthesis by human luteinising granulosa cells. This is the first detailed report of fractalkine and CX3CR1
expression and function in the human ovary.
Methods: Fractalkine and CX3CR1 expression levels were measured by immunohistochemistry using ovarian tissue
from pathological specimens from five individuals. Granulosa cells were obtained from patients during IVF
treatment. They were cultured and treated with increasing doses of hCG with or without fractalkine. Media were
collected to detect estradiol and progesterone by chemiluminescence. StAR, 3-bHSD and CYP11A expression were
determined in granulosa cells treated with or without fractalkine by real-time RT-PCR.
Results: Fractalkine and CX3CR1 were expressed in the human ovary and in luteinising granulosa cells. However,
fractalkine expression was stronger in luteinising granulosa cells. Treatment with fractalkine augmented hCG
stimulation of progesterone production in a dose-dependent manner with concomitant increases in transcript
levels for key steroidogenic enzymes (StAR, 3-bHSD and CYP11A) but had no effect on estradiol biosynthesis(P <
0.05).
Conclusions: Fractalkine and CX3CR1 were found to express in human ovary and luteinising granulosa cells.
Fractalkine can increase the biosynthesis of progesterone in a dose-dependent manner by enhancing transcript
levels of key steroidogenic enzymes.
Background
Previous studies have demonstrated the importance of
multiple intraovarian ligand-receptor signalling systems
in modulating ovarian function. These factors play para-
crine and/or autocrine role(s) in oocyte maturation, ovu-
lation, and luteinisation [1,2]. A critical feature of
o v a r i a nf u n c t i o ni st h ed i f f e rentiation of the ovulatory
follicle into the corpus luteum, which produces steroid
hormones (estradiol, progesterone) that are required for
the initiation and maintenance of pregnancy [3]. Frac-
talkine was found to be localised in rat ovaries and
excreted as an autocrine/paracrine factor to increase
hCG (human chorionic gonadotropin) stimulation of
progesterone [4].
Fractalkine is a chemokine that is synthesised at the
sites of inflammation and is known to be a major regu-
latory protein for leukocyte recruitment and trafficking.
More than 40 chemokines have been identified to date,
and they are subdivided into four subfamilies, C-, CC-,
CXC-, and CX3C-chemokines [5]. Fractalkine (also
known as CX3CL1 or neurotactin) is the only member
of a subclass of chemokines designated as the CX3C
family. Recombinant fractalkine was found to activate a
seven transmembrane receptor CX3CR1 [6].
DNA microarray analysis of mice treated with gonado-
tropin indicated that there were increases in the
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gle injection of hCG, which induced ovulation. Further,
transcript levels for the receptor CX3CR1 displayed
minimal changes during gonadotropin treatment.
Further research in rats has shown that fractalkine is
localised in cumulus, mural granulosa, and theca cells,
as well as in the oocytes, whereas CX3CR1 was found in
the same cells, except for the oocytes. hCG could induce
fractalkine transcripts in different ovarian compart-
ments, with the highest increases found in granulosa
cells. In the cultured granulosa cells of rats, treatment
with fractalkine increased hCG stimulation of progester-
one [4]. It has yet to determine the expression and roles
of fractalkine in human.
To better understand what paracrine and/or autocrine
role(s) fractalkine plays in human ovarian function, we
designed the current study to examine the expression of
fractalkine and its receptor CX3CR1 in human ovaries
and to explore the effects of fractalkine on progesterone
and estradiol production in human luteinised granulosa
cells in vitro.
Methods
Subjects
The experimental protocol was approved by the ethics
committee of Peking University Health Science Center.
Paraffin sections of human ovary tissues were obtained
from the Pathology Department of Peking University
Third Hospital from five patients aged 32-49 years. All
five patients had suffered ovary excision because of
benign ovarian lesions (Table 1). Human luteinised
granulosa cells (GCs) were isolated from follicular aspi-
rates of women undergoing in vitro fertilisation and
embryo transfer (IVF-ET) at the Reproductive Center of
Peking University Third Hospital. All twenty seven
women aged 25-39 years who had regular menstrual
cycles underwent IVF-ET only because of male factors.
Women with a diagnosis of polycystic ovarian syndrome
or endometriosis were excluded.
Immunohistochemistry
To identify and locate the expression of fractalkine and
CX3CR1, after deparaffinisation and rehydration, 5-μm
sections of ovaries were pretreated in EDTA buffer (pH
8.0) for 15 min at 95°C to retrieve antigens. Tissue sec-
tions were then immersed in 1.5% peroxide/methanol
for 15 min to remove endogenous peroxidase activity
followed by blocking in 5% BSA for 60 min. Slides were
incubated with polyclonal rabbit anti-mouse/human/rat
fractalkine (eBioscience Inc, San Diego, United States) at
a 1:200 dilution or polyclonal rabbit anti-mouse/human/
rat CX3CR1 (eBioscience Inc, San Diego, United States)
at a 1:200 dilution for 18 h at 4°C. After three washes in
phosphate-buffered saline (PBS), slides were incubated
with biotin-conjugated anti-rabbit secondary antibodies
(Santa Cruz Biotechnology Inc., Santa Cruz, United
States) for 1 h at 37°C. Tissue sections were then
washed three times and incubated with horseradish per-
oxidase-conjugated streptavidin (Santa Cruz Biotechnol-
ogy Inc., Santa Cruz, United States) for 30 min at 37°C.
Signals were developed using the diaminobenzidine kit
(Santa Cruz Biotechnology Inc., Santa Cruz, United
States), and cell nuclei were stained using hematoxylin
solution (Sigma-Aldrich Inc., St. Louis, United States).
For negative controls, the primary antibodies were
replaced by PBS.
Isolation and culture of granulosa cells
Follicular granulosa cells (GCs) were aspirated from
each patient undergoing IVF-ET, washed in PBS, and
centrifuged over 45% Percoll (Sigma-Aldrich Inc., St.
Louis, United States) to remove red blood cells. The
number of granulosa cells that could be aspirated from
one woman is about from 2 × 10
6 to 3 × 10
6.G C sw e r e
washed again with McCoy’s 5a media (Modified; Invitro-
gen) and then cellular deposits were collected.
GCs were resuspended in McCoy’s 5a medium supple-
mented with 10
-7 M androstenedione, 100 U/ml penicil-
lin, and 100 μg/ml streptomycin and cultured in plates
treated under different conditions. Cells were grown on
the glass coverslips for 24 h in McCoy’s5 am e d i aw i t h
5% fetal bovine serum for immunofluorescence. Cells
were cultured in 48-well plates (Nunclon, Roskilde, Den-
mark) in serum-free McCoy’s 5a media treated with
increasing doses of hCG (Merck Serono, Geneva, Swiss)
with or without recombinant human fractalkine (R&D
Systems, Emeryville, United States) at 100 ng/ml to
determine the possible effects of fractalkine on proges-
terone and estradiol production. To test the dose depen-
dent effects of fractalkine, cells were treated with 20 ng/
ml hCG and varying concentrations of recombinant
fractalkine. Cells were cultured in 6-well plates treated
with 20 ng/ml hCG with or without recombinant
human fractalkine (100 ng/ml) for 48 hours for further
real-time RT-PCR analysis. The number of the cells
seeded in the 48-well plates and in the 6-well plates is
separately 1.5 × 10
5 per well and 1 × 10
6 per well.
Table 1 Information about the patients collected for
immunohistochemical study
Age diagnosis
Patient 1 39 dermoid cyst
Patient 2 42 endometrial cyst
Patient 3 32 dermoid cyst
Patient 4 37 serous cystadenoma
Patient 5 49 endometrial cyst
All five patients underwent unilateral ovary excision
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Cells were grown and attached well on glass coverslips,
as confirmed by microscopic observation. They were
then fixed in methanol for 30 min at 4°C and washed in
PBS. The cells were subsequently subjected to triton-X
100 for 30 min and then to 5% BSA blocking for 60
min. The cells were incubated with polyclonal rabbit
anti-mouse/human/rat fractalkine and polyclonal rabbit
anti-mouse/human/rat CX3CR1 diluted to 1:200 with
blocking solution overnight at 4°C. This was followed by
three washes with PBS containing 0.5% Tween (PBST).
Then the cells were incubated with secondary goat anti-
rabbit fluorescence isothiocyanate (FITC)-conjugated
antibodies diluted to 1:100 for 1 hour at 37°C. After rin-
sing, cell nuclei were stained with PI for 5 min. Finally,
the slides were sealed with 50% glycerol and observed
using a confocal laser scanning microscope (Leica,
Germany).
Measurement of steroids
Media was collected 48 hours after culture and stored at
-80°C until estradiol (E2) and progesterone (P) determi-
nation using chemiluminescence by Immunoassay Sys-
tem (Siemens Healthcare Diagnostics Inc., Deerfield,
United States). The lower limits of detection for E2 and
P were 73.4 pmol/L and 0.6 nmol/L, respectively.
Real-time RT-PCR analysis
To study fractalkine regulation of steroidogenic
enzymes, Sybrgreen-based quantitative RT-PCR was car-
ried out to measure transcript levels of steroidogenic
acute regulatory protein (StAR), 3-b hydroxysteroid
dehydrogenase (3bHSD) and cytochrome P45011A
(CYP11A). Isolated granulosa cells were treated with 20
ng/ml hCG in the presence or absence of 100 ng/ml
fractalkine for 48 h. Cells were washed and collected for
subsequent extraction of total RNA. Total RNA was
extracted using the Trizol reagent (Invitrogen, Carlsbad,
United States) according to the manufacturer’s protocol,
and DNA was removed using the Turbo DNA-free kit
(Ambion, Austin, United States). Based on absorbance
at 260 nm, RNA samples were adjusted to 1 μg/μl
before reverse transcription was performed using Super-
script reverse transcriptase (Invitrogen, Carlsbad, United
States). Real-time PCR was performed in 20 μl reaction
volumes containing 10 μl 2 × Brilliant SYBR Green
quantitative PCR master mix (Applied Biosystems Inc,
Foster City, USA), 2 μl template cDNA, 0.5 μM primers,
and 300 nM reference dye. b-actin was used for normal-
isation; however, the reserve transcription reaction was
omitted for the negative controls. Plasmids of StAR, 3
-bHSD, CYP11A and b-actin were amplified to generate
standard curves after serial dilutions. Realtime RT-PCR
results were analysed using the ABI Prism 7000 SDS
software (Applied Biosystems Inc, Foster City, USA).
The following primers were used:
S t A R ,s e n s e ,5 ’-GAGCAGAAGGGTGTCATCAGG-3’,
antisense, 5’- GCAGGTGGTTGGCAAAATC-3’;3
-bHSD, sense, 5’-CCAGCATCTTCTGTTTCCTGG-3’,
antisense, 5’-AGCTTGGTCTTGTTCTGGAGTTTAG-
3’; CYP11A, sense, 5_ TGGAGTCGGTTTATGTCATCG
-3_, antisense, 5’-GGCCACCCGGTCTTTCTT-3’.
Statistical analysis
All data are presented as the mean ± SD of at least
three independent experiments. The results were ana-
lysed by one-way ANOVA, and P < 0.05 was considered
to be statistically significant.
Results
Expression of fractalkine and its receptor CX3CR1 in the
human ovary
Immunohistochemical analysis from pathological speci-
mens from 5 individuals demonstrated that fractalkine
was expressed in granulosa cells in the follicular phase
in human ovaries. Stronger signals were detected in
luteal tissues and luteinised granulosa cells. For
CX3CR1 staining, comparable levels of signal were
found in granulosa cells in the follicular and luteal
phases. Unlike fractalkine, CX3CR1 expression did not
vary in different phases of the cycle. No signal was
detected in control sections when primary antibodies
were replaced by PBS. (Figure 1)
Location of fractalkine and CX3CR1 in human luteinised
granulosa cells
Observation using a confocal laser scanning microscope
showed that fractalkine was distributed in the cytoplasm
of human luteinised granulosa cells, and CX3CR1 was
expressed in the membranes of human luteinised granu-
losa cells (Figure 2).
Progesterone and estradiol production in cultured human
luteinised granulosa cells treated with hCG and
fractalkine
To study the effects of fractalkine on steroidogenesis, we
isolated and cultured human luteinised granulosa cells
with graded doses of hCG in the presence or absence of
recombinant fractalkine (100 ng/ml). After culturing for
48 h, media progesterone and estradiol levels were
detected by chemiluminescence. As shown in Figure 3A,
progesterone secretion was stimulated dose dependently
by hCG (no statistical differences). When cells were
cotreated with fractalkine and hCG, progesterone pro-
duction was further increased. Although fractalkine
increased hCG-stimulated progesterone production, no
changes in media estradiol levels were found in the
same cultures (Figure 3B).
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Figure 1 Expression of fractalkine and CX3CR1 in the human ovary by immunohistochemistry. A Fractalkine was localised in granulosa
cells in the follicular phase (arrowheads). B Fractalkine was localised in luteinised granulosa cells (arrowheads). C Negative control (the primary
antibodies were replaced by PBS). D CX3CR1 was localised in granulosa cells in the follicular phase (arrowheads). E CX3CR1 was localised in
luteinised granulosa cells (arrowheads). F Negative control (the primary antibodies were replaced by PBS).
B C A
D E F
Figure 2 Location of fractalkine and CX3CR1 in human luteinised granulosa cells by immunofluorescence with polyclonal rabbit anti-
mouse/human/rat fractalkine and polyclonal rabbit anti-mouse/human/rat CX3CR1. A A red fluorescent signal represents the nuclei of
human luteinised granulosa cells. B A green fluorescent signal represents that fractalkine was located in the cytoplasm of human luteinised
granulosa cells. C Composition graph of A and B. D A red fluorescent signal represents the nuclei of human luteinised granulosa cells. E A green
fluorescent signal represents that CX3CR1 was located in the membrane of human luteinised granulosa cells. F Composition graph of D and E.
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production was dose dependent. As shown in Figure 3C,
cells were treated with 20 ng/ml hCG and increasing
concentrations of fractalkine for 48 h. Progesterone bio-
synthesis was enhanced with graded doses of fractalkine.
Regulation of steroidogenic enzymes induced by hCG and
fractalkine in human luteinised granulosa cells
To investigate the mechanisms underlying fractalkine
augmentation of hCG-stimulated progesterone produc-
tion, we performed real-time RT-PCR of key steroido-
genic enzymes StAR, CYP11A, and 3b-HSD. Based on
t h ed o s ed e p e n d e n c yo fp r o g e s t e r o n es t i m u l a t i o n
induced by fractalkine, 100 ng/ml of fractalkine were
chosen. Human luteinised granulosa cells were treated
with 20 ng/ml hCG and with or without 100 ng/ml frac-
talkine for 48 h. Real-time RT-PCR analyses (Figure 4)
indicated that fractalkine cotreatment significantly
increased the hCG stimulation of transcript levels for
StAR, CYP11A, and 3b-HSD (P < 0.05).
Discussion
Our results demonstrate for the first time that fractalk-
ine and CX3CR1 are expressed in human ovarian tissues
and human luteinising granulosa cells. Higher expres-
sion of fractalkine was found in luteinising granulosa
cells than in granulosa cells in the follicular phase. Frac-
talkine can augment biosynthesis of progesterone in a
dose-dependent manner but without affecting estradiol
production by enhancing key steroidogenic enzymes in
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Figure 3 The progesterone and estradiol contents in the medium of cultured human luteinised granulosa cells were determined using
chemiluminescence. A Progesterone content with graded doses of hCG (0, 3, 10, 30, 100 ng/ml) and with or without fractalkine (100 ng/ml); B
Estradiol content with graded doses of hCG (0, 3, 10, 30, 100 ng/ml) and with or without fractalkine (100 ng/ml); C Progesterone content with
graded doses of fractalkine (0, 25, 50, 75, 100, 150 ng/ml) and with hCG (20 ng/ml). *, P < 0.05 compared with corresponding cells treated with
hCG alone.
Huang et al. Reproductive Biology and Endocrinology 2011, 9:95
http://www.rbej.com/content/9/1/95
Page 5 of 8transcript levels. Increased expression of fractalkine/
CX3CR1 can enhance progesterone production in lutei-
nised human granulosa cells, which is consistent with
the results of previous studies on rats [4]. To our
knowledge, this is the first detailed report of fractalkine
and CX3CR1 expression and the first description of
their functions in human ovary and granulosa cells.
As previously described, CX3CR1 is a seven trans-
membrane-spanning G protein coupled receptor
expressed on monocytes, NK cells, and some lympho-
cyte subpopulations [7]. CX3CR1 ligand (CX3CL1), also
called fractalkine, is the sole member of the CX3C-che-
mokine subfamily. The soluble CX3CL1 exerts potent
chemotactic activity [8]. In an in vitro model, fractalkine
has been shown to have multiple activities, including
signal transduction through the G protein-coupled
receptor CX3CR1 and adhesion of monocytes, NK cells,
and T cells in static binding assays [9,10].
Previous studies of fractalkine as a kind of chemokine
were focused on its functio n si na d h e s i o na n dc h e m o -
taxis [11,12], while recent research paid more attention
to the expression and function of chemokines in ovaries.
Fractalkine was found to express in PMSG-primed rat
ovary 6 h post-hCG [13]. Zhao et al. reported that frac-
talkine and CX3CR1 were found to express in the differ-
ent ovarian compartments of rats, and treatment with
fractalkine increased hCG stimulation of progesterone
[4]. These data inspired us to study the function of frac-
talkine in the human ovary.
Our study showed that CX3CR1, the only fractalkine
receptor, was expressed in human granulosa cells, and
immunohistochemical analysis showed higher expression
of fractalkine in luteinised granulosa cells than granulosa
cells in the follicular phase; however, its receptor
expression was not differential. This indicated that frac-
talkine had effects on human ovarian granulosa cells,
especially in the luteinising physiological process. Due
to the scarcity of human ovarian tissue, we chose granu-
losa cells derived from IVF-ET as materials in which to
observe the location of fractalkine and CX3CR1. We
found that fractalkine was expressed in the cytoplasm
while CX3CR1 was expressed in the membrane of lutei-
nised granulosa cells. This finding is consistent with
classical ligand/receptor theory, which states that a
ligand interacts with its receptor in the cell membrane
and then plays its role elsewhere [14].
In our study, progesterone secretion was stimulated
dose dependently by hCG in cultured luteinised granu-
losa cells. Previous studies have shown that IL-1B, pro-
lactin and pituitary adenylate cyclase-activating
polypeptide were found to be increased by the preovula-
tory LH/hCG surge and could promote progesterone
biosynthesis and luteinisation [15-17]. In this study, pro-
gesterone production was further increased when cells
were co-treated with fractalkine and hCG. Fractalkine
significantly stimulated progesterone production in a
dose-dependent manner. Higher expression of fractalk-
ine was found in luteinised granulosa cells than in gran-
u l o s ac e l l si nt h ef o l l i c u l a rp h a s e .A b o v er e s u l t s
indicated that fractalkine plays important roles in the
ovary luteinising process as autocrine/paracrine factors.
The finding that fractalkine could increase hCG-stimu-
lated progesterone production may have clinical rele-
vance in some reproductive endocrine diseases, such as
corpus luteum function defect and polycystic ovary syn-
drome with insufficient progesterone, which results in
menstrual disorder and abortion. Further study may lay
the foundation for clinical treatment of these diseases.
            A                     B                      C 
Figure 4 The effect of fractalkine on the hCG stimulation of transcript levels for different steroidogenic enzymes in cultured granulosa
cells. Isolated granulosa cells were cultured with 20 ng/ml hCG and/or 100 ng/ml fractalkine for 48 h. Transcript levels of StAR (A), CYP11A (B)
and 3b-HSD (C) were quantitated using real-time RT-PCR. Data are represented as the mean ± SE of three independent experiments. A Transcript
levels of StAR; B Transcript levels of CYP11A; C Transcript levels of 3b-HSD. *, P < 0.05 compared to cells treated with hCG alone.
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augmentation of hCG-stimulated progesterone produc-
tion, we measured three key steroidogenic enzymes
levels. Real-time RT-PCR analysis showed that fractalk-
ine cotreatment significantly augmented the hCG stimu-
lation of transcript levels for StAR, CYP11A, and 3b-
HSD. As well known, StAR plays an essential role in
cholesterol transfer from the outer to the inner mito-
chondrial membrane, thus providing the substrate for
steroid hormone biosynthesis. Cholesterol is then con-
verted to pregnenolone by the CYP11A enzyme. 3b-
HSD contributes to the conversion from pregnenolone
to progesterone [18-21]. In our study, accompanied by
increases in the levels of three key steroidogenic
enzymes, progesterone synthesis is up-regulated by the
synergistic effect of fractalkine and hCG. In a previous
study, treatment with fractalkine was found to augment
transcript levels for StAR, CYP11A, and 3b-HSD by
increasing the phosphorylation of P38 MAPK in cul-
tured granulosa cells of rats [4]. This needs to be veri-
fied in human granulose cells. We have to emphasize
that we didn’t try to directly demonstrate the existence
of a functional fractalkine receptor on human granulosa
cells in the current study. Therefore, further functional
assays such as calcium mobilization, chemotaxis or
MAPK kinase assays in human granulosa cells in
response to fractalkine are needed to substantiate the
function of the receptor.
It is interesting to note that no changes in estradiol
production were found with the treatment of fractalkine
compared with increased hCG-stimulated progesterone
production in the same culture. Given the fact that
estrogen is synthesised from progesterone by two path-
ways after ovulation, the relations between fractalkine
and estrogen may be complicated by multiple factors
and pathways. This is an issue deserving further
investigation.
Conclusions
Our study demonstrated for the first time that fractalk-
ine and its receptor CX3CR1 are expressed in the
human ovary. In addition, we showed that fractalkine
could increase progesterone production through enhan-
cing steroidogenic enzymes by fractalkine in luteinised
human granulosa cells. These results build a solid foun-
dation for further exploration of the roles of fractalkine
in reproductive endocrine system and may have implica-
tions for the treatment of related reproductive diseases.
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